Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
391-405 of 2992 results
Abaxis Global Diagnostics and AAHA develop preventive care testing initiative
By MDBR Staff Writer
Abaxis, a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced a partnership with the American Animal Hospital Association (AAHA) to develop a wellness testing initiative that is focused on improving compliance for blood diagnostic testing.
Diagnostics > In Vitro Diagnostics > News
LabCorp launches RealStar Zika virus test in US
By MDBR Staff Writer
Laboratory Corporation of America Holdings (LabCorp) has launched the RealStar Zika virus test in the US.
Diagnostics > In Vitro Diagnostics > News
NantHealth announces commercial availability of GPS Cancer molecular test
By MDBR Staff Writer
NantHealth announced the commercial availability of Genomic Proteomic Spectrometry Cancer, or GPS CancerT, a unique, comprehensive molecular test and decision support solution that measures the proteins present in the patient's tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor & normal samples.
Diagnostics > In Vitro Diagnostics > News
Definiens and MolecularMD partner to combine IHC assays with advanced digital pathology and data mining
By MDBR Staff Writer
Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced a partnership agreement with MolecularMD to combine MolecularMD’s expertise in specialty diagnostic assays with Definiens’ quantitative tissue read-outs.
Diagnostics > In Vitro Diagnostics > News
AstraZeneca, Foundation Medicine partner to develop companion diagnostic assay for Lynparza
By MDBR Staff Writer
AstraZeneca ans Foundation Medicine have collaborated to develop a new companion diagnostic assay for Lynparza (olaparib) oral poly ADP-ribose polymerase (PARP) inhibitor.
Diagnostics > In Vitro Diagnostics > News
Avant acquires Amarantus Diagnostics
By MDBR Staff Writer
Avant Diagnostics has completed the acquisition of Amarantus BioScience's subsidiary Amarantus Diagnostics.
Diagnostics > In Vitro Diagnostics > News
Admera Health launches Archer FusionPlex assay services
By MDBR Staff Writer
ArcherDX, the leader in NGS-based gene fusion detection, announced the addition of renowned molecular diagnostics company Admera Health as a Certified Service Provider (CSP) of Archer® FusionPlex assays.
Diagnostics > In Vitro Diagnostics > News
Roche gets FDA liquid biopsy approval for cobas EGFR mutation test v2
By MDBR Staff Writer
Roche has received liquid biopsy approval from the US Food and Drug Administration (FDA) for cobas EGFR mutation test v2 for use with plasma samples, as a companion diagnostic for the non-small cell lung cancer (NSCLC) therapy.
Diagnostics > In Vitro Diagnostics > News
ArcherDX, Illumina to develop NGS-based in vitro diagnostic tests
By MDBR Staff Writer
ArcherDX has partnered with Illumina to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) tests.
Diagnostics > In Vitro Diagnostics > News
WHO recommends rapid test for extensively resistant tuberculosis
By MDBR Staff Writer
On 12 May 2016 the WHO published a recommendation for the rapid tuberculosis test from the company Hain Lifescience.
Diagnostics > In Vitro Diagnostics > News
Roche introduces CoaguChek INRange self-testing device
By MDBR Staff Writer
Roche has introduced the new CoaguChek INRange system self-testing device which helps patients to spend more time in therapeutic range with minimal training.
Diagnostics > In Vitro Diagnostics > News
Quest Diagnostics introduces three new cancer test services
By MDBR Staff Writer
Quest Diagnostics has introduced three new cancer test services, which will enable clinicians to predict the development of hereditary forms of cancer in individuals.
Diagnostics > In Vitro Diagnostics > News
European Union agrees new rules on medical devices
By MDBR Staff Writer
The European Union (EU) has agreed new rules on medical devices and in vitro diagnostic medical devices.
Diagnostics > In Vitro Diagnostics > News
FDA approves Roche’s CMV test for use in hematopoietic stem cell transplant recipients
By MDBR Staff Writer
The US Food and Drug Administration (FDA) has approved Roche’s cytomegalovirus (CMV) test for use in hematopoietic stem cell transplant recipients.
Diagnostics > In Vitro Diagnostics > News
Biocept announces master services agreement with pharma company to develop liquid biopsy tests
By MDBR Staff Writer
Biocept, a leading molecular diagnostics company with liquid biopsy technology for cancer profiling and monitoring, announces that it has entered into a master services agreement with a biopharmaceutical company to develop targeted liquid biopsy tests for multiple tumor types and molecular targets.
Diagnostics > In Vitro Diagnostics > News
391-405 of 2992 results